[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-343033-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-343033-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","to-study-the-utility-of-cox-2-as-immunohistochemical-prognostic-marker-in-comparison-to-various-histopathological-parameters-and-tnm-staging-in-breast-carcinoma-study-protocol","To study the utility of COX-2 as immunohistochemical prognostic marker in comparison to various histopathological parameters and TNM staging in breast carcinoma - study protocol","","Breast cancer is the most prevalent cancer among women worldwide and a major cause of female cancer mortality. COX-2 (cyclooxygenase), an enzyme involved in arachidonic acid conversion to prostaglandins, supports processes such as proliferation, apoptosis, and angiogenesis, and its overexpression has been linked to poorer prognosis. The protocol outlines an observational, cross-sectional immunohistochemical study quantifying COX-2 expression in breast carcinoma specimens and correlating immunohistochemical scores with histopathological parameters and TNM staging to assess prognostic value.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/to-study-the-utility-of-cox-2-as-immunohistochemical-prognostic-marker-in-comparison-to-various-histopathological-parameters-and-tnm-staging-in-breast-carcinoma-study-protocol/343033/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/to-study-the-utility-of-cox-2-as-immunohistochemical-prognostic-marker-in-comparison-to-various-histopathological-parameters-and-tnm-staging-in-breast-carcinoma-study-protocol/343033.png","ImageObject",300,407,{"name":42,"@type":43},"Liam","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-15","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the study aim regarding COX-2 in breast carcinoma?","Question",{"text":63,"@type":64},"The study aims to evaluate the immunohistochemical expression of COX-2 in breast cancer and compare it with established histopathological parameters to determine its prognostic value.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How will COX-2 expression be measured in the study?",{"text":68,"@type":64},"COX-2 expression will be assessed in radical mastectomy specimens using immunohistochemistry, quantified as an immunohistochemical score.",{"name":70,"@type":61,"acceptedAnswer":71},"Which clinical/pathological factors will COX-2 be correlated with?",{"text":72,"@type":64},"The results will be correlated with histopathological parameters and TNM staging, including factors such as tumor size, lymph node status, T stage, N stage, and lymphovascular invasion.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},343033,1790211902,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},8796095461564,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","STUDY PROTOCOL  \nTo study the utility of COX-2 as immunohistochemical prognostic marker in comparison to various histopathological parameters and TNM staging in breast carcinoma: an observational, cross-sectional study protocol [version 1; peer review: 1 approved, 1 approved with reservations]  \nJayashree Bhawani 1, Samarth Shukla 1, Sourya Acharya2, Sunita Vagha 1, Miheer Jagtap 1  \n1 Department of Pathology, Jawaharlal Nehru Medical college, Sawangi(Meghe), Wardha, Maharashtra, 442001, India  \n2 Department of General Medicine, Jawaharlal Nehru Medical College, Sawangi(Meghe), Wardha, Maharashtra, 442001, India  \nv1  \nFirst published: 30 Aug 2023, 12:1057  \n[https://doi.org/10.12688/f1000research.138776.1](https://doi.org/10.12688/f1000research.138776.1)  \n[Latest published:](Latest published: 18 Jun 2024)[ 18 Jun 2024](Latest published: 18 Jun 2024), 12:1057  \n[https://doi.org/10.12688/f1000research.138776.2](https://doi.org/10.12688/f1000research.138776.2)  \nAbstract  \nBackground: Breast cancer is the most prevalent cancer among women worldwide and is a well-known cause for cancer mortality in females. COX-2 (cyclooxygenase) plays a vital role in development of some human cancers such as lung, colon and breast. It is a potent enzyme that is important for the conversion of arachidonic acid into prostaglandins. These prostaglandins mediate cellular proliferation, apoptosis and angiogenesis which contributes to carcinogenesis. Overexpression of COX-2 has been detected in several malignancies including breast cancer. COX-2 overexpression is regarded as a poor prognostic marker of breast cancer.  \nThe present study will aim to study the immunohistochemical expression of COX-2 in breast cancer and compare it with known histopathological parameters thus assessing its prognostic value. Methods: This will be an observational study conducted in the Department of Pathology, JNMC, Wardha (Sawangi) . Radical mastectomy specimens will be studied for COX-2 expression by immunohistochemistry in patients diagnosed with breast carcinoma. COX-2 expression will be quantified as immunohistochemical score and results will be correlated with various histopathological parameters.  \nResults: The expected result of our study will suggest an association of COX-2 expression to the factors associated with poor prognosis in breast carcinoma. A positive correlation is expected between larger tumor size, positive lymph node status, higher T stage and N stage and lymphovascular invasion.  \nOpen Peer Review  \n\n| Approval Status  |  |\n| --- | --- |\n| 1 | 2 |\n| version 2\u003Cbr>(revision)\u003Cbr>18 Jun 2024\u003Cbr>version 1  \u003Cbr>view view\u003Cbr>30 Aug 2023 |  |\n\n1. Amit Kumar Chowhan, AIIMS, RAIPUR, RAIPUR, India  \n2. Shaan Khetrapal , Hamdard Institute of Medical Sciences and Research, New Delhi, India  \nAny reports and responses or comments on the  \narticle can be found at the end of the article.  \nConclusions: Conclusions will be drawn from the obtained results of the immunohistochemical study by using COX-2-for detection of overexpression of COX-2 when evaluated with TNM staging, histological grading and molecular types of breast cancer.  \nKeywords  \nBreast Cancer, COX-2, histopathological parameters, prognostic marker, immunohistochemistry.  \nThis article is included in the Datta Meghe Institute of Higher Education and Research  \ncollection.  \nCorresponding authors: Jayashree Bhawani ([jayashree1993rey@gmail.com](jayashree1993rey@gmail.com)), Sunita Vagha ([sunita.pathology@dmiher.edu.in](sunita.pathology@dmiher.edu.in))  \nAuthor roles: BhawaniJ: Conceptualization, Investigation, Methodology, Project Administration, Resources, Visualization, Writing – Original Draft Preparation, Writing – Review & Editing; Shukla S: Conceptualization, Formal Analysis, Investigation, Methodology, Project Administration, Supervision, Validation, Visualization, Writing – Review & Editing; Acharya S: Formal Analysis, Resources, Supervision, Validation, Writing – Review & Editing; Vagha S: ","cbCaiijF4f6nraCV","https://ap.wps.com/l/cbCaiijF4f6nraCV","pdf",429536,13,"English","# Abstract\n# Introduction\n# Methods\n# Results\n# Conclusions\n# Keywords","[{\"question\":\"What is the study aim regarding COX-2 in breast carcinoma?\",\"answer\":\"The study aims to evaluate the immunohistochemical expression of COX-2 in breast cancer and compare it with established histopathological parameters to determine its prognostic value.\"},{\"question\":\"How will COX-2 expression be measured in the study?\",\"answer\":\"COX-2 expression will be assessed in radical mastectomy specimens using immunohistochemistry, quantified as an immunohistochemical score.\"},{\"question\":\"Which clinical/pathological factors will COX-2 be correlated with?\",\"answer\":\"The results will be correlated with histopathological parameters and TNM staging, including factors such as tumor size, lymph node status, T stage, N stage, and lymphovascular invasion.\"}]","To study the utility of COX-2 as immunohistochemical prognostic marker in comparison to various histopathological parameters and TNM staging in breast carcinoma - study protocol | PDF",1790049502,33,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fe895f2a7d41caf02360a34876266057.webp",983,1272,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/72f777c75ad3ad591d5a5d5a1143d6e9.webp",982,1270,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a2996229c2a5ec330daaaa5773a222b0.webp",981,1269,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/adb2c54d82018be96ff92f2d234be784.webp",980,1268]